%0 Journal Article
%A Lisenko, Katharina
%A Wuchter, Patrick
%A Hansberg, Marion
%A Mangatter, Anja
%A Benner, Axel
%A Ho, Anthony D
%A Goldschmidt, Hartmut
%A Hegenbart, Ute
%A Schönland, Stefan
%T Comparison of Different Stem Cell Mobilization Regimens in AL Amyloidosis Patients.
%J Biology of blood and marrow transplantation
%V 23
%N 11
%@ 1083-8791
%C [S.l.]
%I Elsevier Health Sciences
%M DKFZ-2017-06129
%P 1870 - 1878
%D 2017
%X High-dose melphalan (HDM) and autologous blood stem cell transplantation (ABSCT) is an effective treatment for transplantation-eligible patients with systemic light chain (AL) amyloidosis. Whereas most centers use granulocyte colony-stimulating factor (G-CSF) alone for mobilization of peripheral blood stem cells (PBSC), the application of mobilization chemotherapy might offer specific advantages. We retrospectively analyzed 110 patients with AL amyloidosis who underwent PBSC collection. Major eligibility criteria included age <70 years and cardiac insufficiency New York Heart Association ≤III°. Before mobilization, 67 patients (61
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:28754546
%R 10.1016/j.bbmt.2017.07.015
%U https://inrepo02.dkfz.de/record/131062